IVUS Study for SV Graft: Y-composite vs Aortocoronary Conduit
CONFIG
Morphologic Changes of the Saphenous Vein as Y-composite Graft Based on the Left Internal Thoracic Artery Versus Aortocoronary Conduit for Coronary Artery Bypass Grafting: A Prospective Randomized Controlled Trial
1 other identifier
interventional
50
1 country
1
Brief Summary
Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG. In our institution, saphenous vein has been primarily used for the second graft and we have harvested it with 'No touch technique'. We have been demonstrated the excellent long-term patency of this 'No touch saphenous vein' in many studies. However, it is still unknown which configuration is the better strategy for the saphenous vein as a Y-composite graft based on the left internal thoracic artery versus an aortocoronary conduit. Thus, we aimed to evaluate morphologic change of saphenous vein graft by 1-year intravascular ultrasound (IVUS) study and angiographic patency results between Y-composite graft and aortocoronary conduit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable coronary-artery-disease
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2021
CompletedFirst Posted
Study publicly available on registry
March 4, 2021
CompletedStudy Start
First participant enrolled
July 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 27, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 27, 2023
CompletedApril 19, 2024
April 1, 2024
2.2 years
March 2, 2021
April 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intima-media thickness (IMT)
Intima-media thickness measured by intravascular ultrasound (IVUS)
at postoperative 1 year
Secondary Outcomes (6)
Lumen diameter (LD)
at postoperative 1 year
Graft patency
at postoperative 1 year
All cause mortality
at postoperative 1 year
Cardiac death
at postoperative 1 year
Target vessel revascularization
at postoperative 1 year
- +1 more secondary outcomes
Study Arms (2)
Y-composite graft
EXPERIMENTALThe saphenous vein is anastomosed to the middle portion of the left internal thoracic artery as Y-composite fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
aortocoronary conduit
ACTIVE COMPARATORThe saphenous vein is anastomosed to the ascending aorta as aortocoronary fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
Interventions
Saphenous vein could be used as Y-composite graft or aortocoronary conduit during coronary artery bypass grafting
Eligibility Criteria
You may qualify if:
- A patient who is going to receive coronary artery bypass grafting
- Older than 19 years
- Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft
You may not qualify if:
- Other concomitant procedures (e.g. valve or aorta surgery) is planned
- Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer)
- Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ho Young Hwanglead
Study Sites (1)
Seoul National University Hospital
Seoul, South Korea
Related Publications (1)
Sohn SH, Kang Y, Kim JS, Kang J, Hwang HY. Morphologic changes of the no-touch saphenous vein as Y-composite versus aortocoronary grafts (CONFIG Trial). PLoS One. 2025 May 8;20(5):e0322176. doi: 10.1371/journal.pone.0322176. eCollection 2025.
PMID: 40338976DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ho Young Hwang, MD, PhD
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 2, 2021
First Posted
March 4, 2021
Study Start
July 8, 2021
Primary Completion
September 27, 2023
Study Completion
September 27, 2023
Last Updated
April 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because it is not allowed by our Institutional Review Board.